Of the millions of vaccines administered in the United States, only 71 people have had a serious reaction.
More than 22 million Americans have gotten at least one dose of the available COVID-19 vaccines with no serious medical problems beyond allergic reactions, the Centers for Disease Control and Prevention (CDC) reported Wednesday.
Dr. Tom Shimabukuro, deputy director of the CDC’s Immunization Safety Office, presented the agency’s safety data to a CDC advisory committee. The information was collected through several channels, including the CDC’s Vaccine Adverse Event Reporting System, or VAERS, which accepts reports from anyone; the Vaccine Safety Datalink, a collaboration between the CDC and nine major hospital systems that collect data on more than 12 million people annually; V-safe, a self-reporting system for people who’ve been vaccinated; and the Clinical Immunization Safety Assessment Project (CISA), a collaboration between the CDC and vaccine safety experts.
Although side effects are commonly linked to the Pfizer-BioNTech and Moderna vaccines, with 70% of people self-reporting some type of pain, the early tracking systems have found few unusual or dangerous results. Fatigue, headaches, muscle pain, chills, fever, swelling, or joint pain were among the most common effects reported.
Very rarely, anaphylaxis, or severe allergic reactions, occur following vaccination. There have been 71 of these cases reported of the 22 million doses administered; that’s about five instances of anaphylaxis for every million doses of the Pfizer vaccine and three for every million doses of the Moderna vaccine.
Through Jan. 18, 196 people have died after getting a vaccine. Of these deaths, 129 (66%) were patients in long-term care residential facilities. About 1.3 million nursing home residents were vaccinated between Dec. 21 and Jan. 18, and researchers found the number of deaths comparable to expected for that general population. The deaths did not appear to be vaccine-related, according to Dr. Shimabukuro.
“These findings suggest that short-term mortality rates appear unrelated to vaccination for COVID-19,” Shimabukuro said.
More vaccines are on the horizon. The CDC panel also heard an update from AstraZeneca on its developing vaccine, which is currently in Phase III of US clinical trials. The company could be ready to submit for an Emergency Use Authorization by the end of March, with a possible approval by the Federal Drug Administration as early as April.
Politics
Influencers and creators find new ways to engage young Philadelphia voters
Rec Philly, a space for creators and influencers, teamed up with Show Up Strong to get hundreds of young Philadelphia residents engaged in the...
New Biden rule protects privacy of women seeking abortions
Under the new rules, state officials and law enforcement cannot obtain medical records related to lawful reproductive health care with the goal of...
Biden marks Earth Day by announcing $7 billion in solar grants
The Biden administration on Monday announced the recipients of its Solar For All Program, a $7 billion climate program that aims to lower energy...
Local News
Conjoined twins from Berks County die at age 62
Conjoined twins Lori and George Schappell, who pursued separate careers, interests and relationships during lives that defied medical expectations,...
Railroad agrees to $600 million settlement for fiery Ohio derailment, residents fear it’s not enough
Norfolk Southern has agreed to pay $600 million in a class-action lawsuit settlement for a fiery train derailment in February 2023 in eastern Ohio,...